NeuroSigma completes a $1M investment in high-volume manufacturing for its drug-free ADHD device. Learn how the Monarch eTNS ...

TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private ...

AngioDynamics stock is undervalued, with Med Tech growth in thrombus management and atherectomy. Learn more about the company ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has increased the size of its private placement previously announced on December 19, 2025 ...

For more than 80 years, men have been told that testosterone fuels prostate cancer. But a more nuanced picture has emerged ...

Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.

Profound Medical (Nasdaq:PROF) announced today that it sold shares of common stock worth proceeds of up to $40 million.

Alpha Tau Medical Ltd ($DRTS) announced an update on their ongoing clinical study. Alpha Tau Medical Ltd (DRTS) has recently completed a clinical ...

Francis Medical recently won FDA 510(k) clearance for its Vanquish Water Vapor Ablation System, a new device for minimally invasive prostate ablation. The Vanquish system uses water vapor for focal ...

The FDA has approved the Vanquish Water Vapor Ablation System, which uses steam to destroy prostate tumors. However, the efficacy of the device in eliminating cancer has yet to be established, ...

MINNEAPOLIS, Dec. 2, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System for the management of ...